Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Public Health Funding Faces Grim Prospects Before, After Election

Executive Summary

FDA, NIH officials urge permanent 'emergency defense fund' for public health as Zika and 21st Century Cures bills stall on Capitol Hill.

You may also be interested in...



US FDA Gains Budget Increase In FY 2017… And Not Through Fees

Omnibus legislation to fund the federal government for FY 2017 includes an increase in non-user fee funds, which should please stakeholders.

Flu Hunters: House Committee Searches For Pandemic Plan

Update to 2005 outline of US response to pandemic influenza was due at the end of 2016, but has yet to be released.

NIH's Zika Vaccine Faces Funding Challenge After Skipping Industry Partnership

Agency wanted to move fast, but is now scrambling to pay for Phases I and II trials.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS119100

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel